Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > A. Keith Goldan > Profile

A. Keith Goldan

Affiliations

  • Chief Financial Officer at Syndax Pharmaceuticals Inc (SNDX), 2024-02-09
  • Chief Financial Officer at Optinose Inc. (OPTN), 2022-03-17
  • Svp And Cfo at Fibrocell Science Inc. (FCSC), 2016-03-02
  • Cfo And Svp at Nupathe Inc. (PATH), 2014-02-25
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Optinose Inc.
 OPTN $3.90 2,500 Officer 9,751 2020-09-23 Filing
Fibrocell Science Inc.
 FCSC $6.33 2,000 Officer 2,000 2015-08-11 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Syndax Pharmaceuticals Inc
 SNDX $22.31 577 2,628 2023-06-13 Filing
Optinose Inc.
 OPTN $2.11 4,617 Officer 141,726 2022-03-16 Filing
Optinose Inc.
 OPTN $1.64 580 Officer 89,613 2021-12-16 Filing
Optinose Inc.
 OPTN $2.79 578 Officer 90,193 2021-09-16 Filing
Optinose Inc.
 OPTN $3.73 576 Officer 90,771 2021-06-17 Filing